Navigation Links
Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
Date:2/15/2012

SAN DIEGO, Feb. 15, 2012 /PRNewswire/ -- Ellen Morgan, former co-founder, president and CEO of Synteract, has launched a non-profit contract research organization (CRO), Public Health Alliance for Clinical Trials (PHACT).  Morgan is joined by two co-founding partners, Christian Sacher of Germany, and Yaw Asare-Aboagye, a native of Ghana. PHACT, founded in May 2011 by Morgan, is conducting clinical trials for biotech and pharmaceutical products to treat diseases disproportionately affecting the poorest people in developing countries. The organization has capabilities in the U.S. and throughout Eastern Europe and opened an office in Dhaka, Bangladesh in November 2011, and last week in Accra, Ghana.

(Logo: http://photos.prnewswire.com/prnh/20120215/LA53835LOGO)

PHACT's focus is to build operations in areas where the need exists but CRO infrastructure is lacking. Utilizing its strong functional management in the U.S., the organization is training to build local know-how in clinical trials, which helps local economies in these countries. Initially the organization will also collaborate with local CROs in other developing countries as appropriate; future plans are to establish offices throughout Sub-Saharan Africa, India, and other parts of Asia. The goal is to support non-profit product development partners (PDPs) and pharmaceutical companies with trials in diseases such as malaria, cholera, dengue fever, tuberculosis, parasitic diseases as well as women's health issues.

"I spent 30 years working on clinical trials for many important new treatments but often wished there was more we could do to help the people with the greatest need," says Morgan. "While new
'/>"/>

SOURCE PHACT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Former Deputy Commissioner of FDA Highlights Value of Small Distributors
2. Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend
3. Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
4. Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary
5. Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator
6. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
7. Meaningful Use Certification Awarded to Press Ganeys Quality Performer(SM)
8. OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors
9. Texas & U.S. Drug Treatment Gap to Be Highlighted at News Conference 11 a.m. June 23 By Former U.S. Drug Czar, U.S. Music Industry/Grammys Addiction Services Leader, Miss Texas 2007, San Antonio Police Chief, Nations Leading Treatment CEO, Experts
10. Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain
11. Former Pfizer Inc. Senior Director Joins Growing MusclePharm Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... A new Manhattan Research study, ... finds that members of pharmacy and therapeutics ... and pharmacy benefits managers (PBMs) are shifting the ... of formulary decision makers report that they are ... decision making process today than a year ago. ...
(Date:7/14/2014)...  Clinicians at a leading cancer center in ... first in the country to commence advanced lung, ... Clinac® medical linear accelerator from Varian Medical Systems ... High Intensity Mode dose delivery capability, which is ... treatment times and deliver stereotactic body radiotherapy and ...
(Date:7/14/2014)... 14, 2014  Patients and patient advocates are rallying ... and other major pharmacy benefit managers (PBMs) begin unprecedented ... impact millions of patients who rely on compounded medicines ... pain from cancer, diabetes and other illnesses. Express Scripts ... on July 15. In a matter of ...
Breaking Medicine Technology:Digital Resources Play Critical Role in Formulary Decision Making 2Digital Resources Play Critical Role in Formulary Decision Making 3Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator 2Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 2Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 4
... SOUTHAMPTON, England, June 29 Vantia ... drugs,targeting large, underserved medical markets, announces positive results ... development compound VA106483 for,nocturia. The trial showed that ... sustained anti-diuretic effect in patients, as determined by,increased ...
... England and TOKYO, June 29 , ... Sosei Group Corporation ("Sosei"; TSE Mothers ... commencement of a Phase III,clinical study by Novartis, with NVA237, ... obstructive pulmonary disease,(COPD). NVA237 is a dry powder formulation for ...
Cached Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4
(Date:7/14/2014)... July 14, 2014 Felicity Philp was diagnosed ... 29 years old. Instead of letting her health issues decrease ... food she was eating and began to see a difference ... two friends and business partners, Julie Reardon and Kate Owen, ... help others with this lifestyle change as well. In their ...
(Date:7/14/2014)... Georgia State University is starting four new ... round of its Second Century Initiative, aiming to ... performance. , The Second Century Initiative (2CI) ... to the university, with the goal of building ... significance. , “With the fifth round of the ...
(Date:7/14/2014)... , Scientists funded by the National Institutes of Health ... esophagitis (EoE), an inflammatory disease characterized by high ... Their findings suggest that several genes are involved in ... and often is associated with food allergies. The findings ... the esophagus. The work was supported in part by ...
(Date:7/14/2014)... PA, July 14, 2014 The inability to ignore ... often experienced by individuals diagnosed with schizophrenia, reports a ... Psychiatry . , Our brains are usually good at ... learn and filtering out the "noise" or thoughts that ... related in part to a problem with this filtering ...
(Date:7/14/2014)... Hicksville and Hauppauge, NY (PRWEB) July 14, 2014 ... York (RGONY), with offices in Hicksville and Hauppauge, ... intravitreal implant) as a long-lasting treatment for diabetic ... by Allergan, recently obtained an additional FDA-approved indication ... previously approved by the FDA in 2009 for ...
Breaking Medicine News(10 mins):Health News:Women Changing Lives Through Food 2Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 2Health News:Georgia State Starts Four Innovative Research Groups Through Fifth Round of Its Second Century Initiative 3Health News:Scientists deepen genetic understanding of eosinophilic esophagitis 2Health News:'Noisy' memory in schizophrenia 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 3
... ... ... ... ...
... who have both diabetes and major depression are more than ... diabetes only, according to a study published in the recent ... the progressive decline of thinking and reasoning abilities. These can ... the past, personality changes, and not recognizing familiar people. ...
... researchers say , FRIDAY, March 5 (HealthDay News) -- Freezing ... mice, a new study has found. , Researchers tested two ... applying a cold probe to the tumor, but one method ... the other takes a few minutes. The mice that received ...
... ... ... ... ...
... , ... ... ... ...
... report released today by Rice University,s Jones Graduate School of ... since October 2009, current Toyota owners are not yet wavering ... The rigorous survey-based study of a national sample ... satisfaction with their vehicles, quality was equally high among Toyota ...
Cached Medicine News:Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 2Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 3Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 4Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 5Health News:Pennsylvania to Observe 'Problem Gambling Awareness Week'; Remind Residents of Available Counseling and Treatment Services 6Health News:Major depression more than doubles risk of dementia among adults with diabetes 2Health News:Major depression more than doubles risk of dementia among adults with diabetes 3Health News:Freezing Technique May Stop Breast Cancer 2Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 2Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 3Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 4Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 5Health News:COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology 6Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 2Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 3Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 4Health News:Summit Seeks to Spark Call to Action on Facing World's Biggest Challenges 5Health News:Survey: Toyota owners maintain high overall satisfaction despite recalls 2
Disposable Feather Blades, 50 per pack...
Knife sharpening back for Standard Knife, C Profile...
... The Cryostage freezing stage is a refrigerated design ... holder, primarily for use with the 8000 sledge ... sledge microtomes. ,The refrigerated stage gives a large ... surface is ridged to provide good adhesion between ...
... necessary to cool a specimen below room temperature. ... most microtomes and will permit specimen cooling from ... The equipment consists of a cooling stage and ... suited for operation with a base sledge microtome, ...
Medicine Products: